Contact
Home
Sitemap
Careers
About Us
Corporate Overview
Executive Management
Board Of Directors
Scientific Advisory Board
Careers
Pipeline
Pipeline Overview
Azedra™
Onalta™
Solazed™
Trofex™
Zemiva™
Molecular Medicine
Molecular Medicine Overview
Targeted Radiotherapeutics
Molecular Imaging Pharmaceuticals
Proprietary Technologies
Scientific Presentations
Scientific Posters
Bibliography
In The Clinic
Clinical Trials Overview
Oncology Trials
Cardiovascular Trials
Patient Resources
Investor Center
Media Room
Media Room Overview
Press Releases
Glossary
Scientific Presentations
Scientific Posters
Bibliography
Media Room
Media Room Overview
Press Releases
Archive
Glossary
Scientific Presentations
Scientific Posters
Bibliography
Media Room
>>
Press Releases
>>
Archive
Archive
2006
|
2005
|
2004
|
2003
2006
Date
Publication
06/22/06
Molecular Insight Pharmaceuticals, Inc. Initiates Azedra™ Phase 1 Clinical Trial for Treatment of Neuroendocrine Cancer
06/07/06
Molecular Insight Pharmaceuticals, Inc. Presents Azedra™ (Ultratrace™ MIBG) Preclinical Data at Society of Nuclear Medicine Meeting
05/31/06
Molecular Insight Pharmaceuticals' SAAC™ Technology Data Published in Bioconjugate Chemistry
04/12/06
David M. Stack Joins Board of Directors of Molecular Insight Pharmaceuticals, Inc.
03/27/06
Molecular Insight Pharmaceuticals, Inc. Begins Phase 2 Zemiva™ Trial for Compilation of Normal Cardiac Images
02/16/06
Molecular Insight Pharmaceuticals, Inc. and MDS Nordion Enter Manufacturing Agreement for Cardiac Molecular Imaging Pharmaceutical Zemiva™
02/08/06
Molecular Insight Pharmaceuticals, Inc. Receives Orphan Drug Designation for Ultratrace™ MIBG for Treatment of Neuroendocrine Tumors
2005
Date
Publication
11/08/05
Molecular Insight Pharmaceuticals, Inc. Files Registration Statement For Proposed Initial Public Offering
09/26/05
Molecular Insight Pharmaceuticals Announces Publication of Phase 2a Zemiva™ (BMIPP) Trial Results in Circulation
08/18/05
Molecular Insight Expands Executive Research and Development Team
07/21/05
Molecular Insight Pharmaceuticals Announces Management Additions
06/21/05
FierceBiotech Honors Molecular Insight Pharmaceuticals as One of the "Fierce 15" Biotech Companies of 2005
06/01/05
Molecular Insight Pharmaceuticals Appoints Two New Vice Presidents, James Wachholz and Joshua Hamermesh
04/21/05
Molecular Insight Pharmaceuticals Raises $28 Million to Advance Cardiac Ischemia Imaging Pharmaceutical into Phase 3 Trials
2004
Date
Publication
08/26/04
Molecular Insight Pharmaceuticals and University of Maryland Share NIH Grant
07/21/04
New Fluorescence-Based Technology Allows Visualization of Cellular Activity of Molecular Imaging Pharmaceutical Candidates
06/29/04
Molecular Insight Pharmaceuticals Augments Research and Development Capability with Key Hire and Appointment of Two New Board Members
06/22/04
Prostate Tumor Angiogenesis Successfully Targeted by Radiopharmaceutical Designed for Diagnosis and Treatment
06/17/04
MDS Nordion to manufacture Molecular Insight’s lead molecular imaging pharmaceutical
05/20/04
Molecular Insight Pharmaceuticals, Inc. Completes Series B Financing
2003
Date
Publication
10/16/03
Molecular Insight Pharmaceuticals Awarded Three NIH Grants
06/19/03
Molecular Insight Pharmaceuticals, Inc. Names New CEO